FDMT 4D Molecular Therapeutics, Inc.
$13.17▼ -2.37%
Healthcare
Other
After hours
$13.16▼ -0.08%
Sep 11, 7:56 PM ET
Volume 481.1K
Avg Volume (10D) 777.2K
Key Metrics & Fundamentals
Market Cap
$727.57M
P/E Ratio
–
Div Yield
–%
52W Range
6.47 - 16.93
% vs 50 MA
4.49%
% vs 200 MA
29.50%
RSI-14
45.2
MACD Histogram
-0.3200
Beta (1Y vs SPY)
1.95
Free Cash Flow
-$70.05M
Gross Rev
$3.78M
Gross Profit
$3.78M
EBITDA
-$74.94M
COGS
–
Operating Exp
$80.81M
Operating Income
-$77.03M
EBIT
-$77.03M
Pretax Income
-$72.94M
Net Income
-$72.94M
EPS (Diluted)
-1.04
Price & Volume History
Loading chart…
Recent News
4DMT Announces New Employment Inducement Grants
GlobeNewswire · Sep 11, 2026 8:05 PM
4DMT to Participate in Upcoming Investor Conferences
GlobeNewswire · Aug 25, 2026 12:00 PM
OCUL, FDMT Stock Clock Best Day In Weeks After EyePoint’s Trial Setback — Here’s Why
Stocktwits · Aug 17, 2026 11:51 PM
4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 13, 2026 10:05 PM
4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
GlobeNewswire · Aug 13, 2026 8:05 PM
MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 13, 2026 12:15 PM
Collegium Pharmaceutical (COLL) Beats Q2 Earnings and Revenue Estimates
Zacks · Aug 6, 2026 1:50 PM
Bioventus (BVS) Q2 Earnings Meet Estimates
Zacks · Aug 5, 2026 1:00 PM
Roblox downgraded, Quanta Services upgraded: Wall Street's top analyst calls
The Fly · Jul 31, 2026 1:46 PM
B. Riley Initiates 4D Molecular Therapeutics at Buy With $37 Price Target
MT Newswires · Jul 31, 2026 1:33 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See FDMT's money flow as a full page
Social Sentiment
Avg +0.60 · 3 posts
DiscussionFavorite mid-cap biotech with the most upside? (500M–2.5B mkt cap)
r/investing · Dec 22, 2025
Mentioned as a potential investment, contributing to discussion.
positive
+0.40
Discussion$ FDMT
r/options · Aug 3, 2025
The post uses strong positive emojis and an exclamation mark, indicating excitement about the stock.
positive
+0.60
Ripe for picking - (FDMT) 4D Molecular Therapeutics?
r/stocks · Oct 20, 2024
The post presents a bullish case for FDMT, detailing the market opportunity and potential revenue, indicating positive sentiment.
positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.